메뉴 건너뛰기




Volumn 27, Issue 25-26, 2009, Pages 3401-3404

Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer

Author keywords

Cancer; Immunotherapy; Poly (I:C12U); Toll like 3

Indexed keywords

AMPLIGEN; CYTOKINE; TOLL LIKE RECEPTOR 3;

EID: 67349117313     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.071     Document Type: Article
Times cited : (121)

References (33)
  • 2
    • 37849046096 scopus 로고    scopus 로고
    • TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours
    • Conroy H., Marshall N.A., and Mills K.H. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene 27 January 7 (2) (2008) 168-180
    • (2008) Oncogene , vol.27 , Issue.January 7 2 , pp. 168-180
    • Conroy, H.1    Marshall, N.A.2    Mills, K.H.3
  • 3
    • 37849035627 scopus 로고    scopus 로고
    • TLR signaling by tumor and immune cells: a double-edged sword
    • Huang B., Zhao J., Unkeless J.C., Feng Z.H., and Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27 2 (2008) 218-224
    • (2008) Oncogene , vol.27 , Issue.2 , pp. 218-224
    • Huang, B.1    Zhao, J.2    Unkeless, J.C.3    Feng, Z.H.4    Xiong, H.5
  • 4
    • 35748966158 scopus 로고    scopus 로고
    • PolyI:C induction of diabetes is controlled by Iddm4 in rats with a full regulatory T cell pool
    • Hornum L., Lundsgaard D., and Markholst H. PolyI:C induction of diabetes is controlled by Iddm4 in rats with a full regulatory T cell pool. Ann N Y Acad Sci 1110 (2007) 65-72
    • (2007) Ann N Y Acad Sci , vol.1110 , pp. 65-72
    • Hornum, L.1    Lundsgaard, D.2    Markholst, H.3
  • 6
    • 0033105695 scopus 로고    scopus 로고
    • Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells
    • Steinbrink K., Jonuleit H., Muller G., Schuler G., Knop J., and Enk A.H. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93 5 (1999) 1634-1642
    • (1999) Blood , vol.93 , Issue.5 , pp. 1634-1642
    • Steinbrink, K.1    Jonuleit, H.2    Muller, G.3    Schuler, G.4    Knop, J.5    Enk, A.H.6
  • 7
    • 0042931259 scopus 로고    scopus 로고
    • + T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism
    • + T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism. J Immunol 171 5 (2003) 2251-2261
    • (2003) J Immunol , vol.171 , Issue.5 , pp. 2251-2261
    • Xu, S.1    Koski, G.K.2    Faries, M.3    Bedrosian, I.4    Mick, R.5    Maeurer, M.6
  • 8
    • 0030603986 scopus 로고    scopus 로고
    • Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
    • Bender A., Sapp M., Schuler G., Steinman R.M., and Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196 2 (1996) 121-135
    • (1996) J Immunol Methods , vol.196 , Issue.2 , pp. 121-135
    • Bender, A.1    Sapp, M.2    Schuler, G.3    Steinman, R.M.4    Bhardwaj, N.5
  • 9
    • 0033168630 scopus 로고    scopus 로고
    • Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells
    • Verdijk R.M., Mutis T., Esendam B., Kamp J., Melief C.J., Brand A., et al. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol 163 1 (1999) 57-61
    • (1999) J Immunol , vol.163 , Issue.1 , pp. 57-61
    • Verdijk, R.M.1    Mutis, T.2    Esendam, B.3    Kamp, J.4    Melief, C.J.5    Brand, A.6
  • 10
    • 0017108014 scopus 로고
    • A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors
    • Robinson R.A., DeVita V.T., Levy H.B., Baron S., Hubbard S.P., and Levine A.S. A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. J Natl Cancer Institute 57 (1976) 599-602
    • (1976) J Natl Cancer Institute , vol.57 , pp. 599-602
    • Robinson, R.A.1    DeVita, V.T.2    Levy, H.B.3    Baron, S.4    Hubbard, S.P.5    Levine, A.S.6
  • 12
    • 9444284910 scopus 로고    scopus 로고
    • Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI: polyC12U in the treatment of HIV infection
    • Thompson K.A., Strayer D.R., Salvato P.D., Thompson C.E., Klimas N., Molavi A., et al. Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI: polyC12U in the treatment of HIV infection. Eur J Clin Microbiol Infect Dis 15 7 (1996) 580-587
    • (1996) Eur J Clin Microbiol Infect Dis , vol.15 , Issue.7 , pp. 580-587
    • Thompson, K.A.1    Strayer, D.R.2    Salvato, P.D.3    Thompson, C.E.4    Klimas, N.5    Molavi, A.6
  • 14
    • 0037472447 scopus 로고    scopus 로고
    • Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]: poly [C12U] (Ampligen R)
    • Adams M., Navabi H., Jasani B., Man S., Fiander A., Evans A.S., et al. Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]: poly [C12U] (Ampligen R). Vaccine 21 (2003) 787-790
    • (2003) Vaccine , vol.21 , pp. 787-790
    • Adams, M.1    Navabi, H.2    Jasani, B.3    Man, S.4    Fiander, A.5    Evans, A.S.6
  • 15
    • 56949108633 scopus 로고    scopus 로고
    • ®) promotes DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro
    • ®) promotes DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine 27 (2009) 107-115
    • (2009) Vaccine , vol.27 , pp. 107-115
    • Navabi, H.1    Jasani, B.2    Reece, A.3    Clayton, A.4    Tabi, Z.5    Mason, M.6
  • 17
    • 0035879893 scopus 로고    scopus 로고
    • A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
    • Jonuleit H., Giesecke-Tuettenberg A., Tüting T., Thurner-Schuler B., Stuge T.B., Paragnik L., et al. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer 93 2 (2001) 243-251
    • (2001) Int J Cancer , vol.93 , Issue.2 , pp. 243-251
    • Jonuleit, H.1    Giesecke-Tuettenberg, A.2    Tüting, T.3    Thurner-Schuler, B.4    Stuge, T.B.5    Paragnik, L.6
  • 18
    • 33745712871 scopus 로고    scopus 로고
    • C. Dendritic cells in a mature age
    • Sousa R.e. C. Dendritic cells in a mature age. Nat Rev Immunol 6 6 (2006) 476-483
    • (2006) Nat Rev Immunol , vol.6 , Issue.6 , pp. 476-483
    • Sousa, R.e.1
  • 19
    • 1442348476 scopus 로고    scopus 로고
    • Restoration of tumor specific human leukocte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocy in patients with advanced ovarian cancer
    • Santin A.D., Bellone S., Palmieri M., Bossini B., and Pecorelli S. Restoration of tumor specific human leukocte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocy in patients with advanced ovarian cancer. Int J Gynecol Cancer 14 (2004) 64-75
    • (2004) Int J Gynecol Cancer , vol.14 , pp. 64-75
    • Santin, A.D.1    Bellone, S.2    Palmieri, M.3    Bossini, B.4    Pecorelli, S.5
  • 21
    • 31544480872 scopus 로고    scopus 로고
    • + T cells exceeds that of an aggressively growing mouse tumor
    • + T cells exceeds that of an aggressively growing mouse tumor. Cancer Res 66 2 (2006) 1132-1138
    • (2006) Cancer Res , vol.66 , Issue.2 , pp. 1132-1138
    • Hwang, L.N.1    Yu, Z.2    Palmer, D.C.3    Restifo, N.P.4
  • 23
    • 0242579946 scopus 로고    scopus 로고
    • CD8, T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine
    • Curtsinger J.M., Johnson C.M., and Mescher M.F. CD8, T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J Immunol 171 10 (2003) 5165-5171
    • (2003) J Immunol , vol.171 , Issue.10 , pp. 5165-5171
    • Curtsinger, J.M.1    Johnson, C.M.2    Mescher, M.F.3
  • 24
    • 14844303287 scopus 로고    scopus 로고
    • The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer
    • Adams M., Navabi H., Croston D., Coleman S., Tabi Z., Clayton A., et al. The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer. Vaccine 23 17-18 (2005) 2374-2378
    • (2005) Vaccine , vol.23 , Issue.17-18 , pp. 2374-2378
    • Adams, M.1    Navabi, H.2    Croston, D.3    Coleman, S.4    Tabi, Z.5    Clayton, A.6
  • 26
    • 0033697454 scopus 로고    scopus 로고
    • CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal.
    • Schulz O., Edwards A.D., Schito M., Aliberti J., Manickasingham S., Sher A., et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13 (2000) 453-462
    • (2000) Immunity , vol.13 , pp. 453-462
    • Schulz, O.1    Edwards, A.D.2    Schito, M.3    Aliberti, J.4    Manickasingham, S.5    Sher, A.6
  • 27
    • 4344596051 scopus 로고    scopus 로고
    • alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity
    • Mailliard R., Wankowicz-Kalinska A., Hilkens C., Kapsenberg M., and Kalinski P. alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res 64 (2004) 5934-5937
    • (2004) Cancer Res , vol.64 , pp. 5934-5937
    • Mailliard, R.1    Wankowicz-Kalinska, A.2    Hilkens, C.3    Kapsenberg, M.4    Kalinski, P.5
  • 28
    • 0030963666 scopus 로고    scopus 로고
    • Human dendritic cells require exogenous iterleukin-12 inducing factor to direct the developmentof naive T-Helper cells toward the Th1 phenotype
    • Hilkens C., Kalinski P., BoerF M.de, and Kapsenberg M. Human dendritic cells require exogenous iterleukin-12 inducing factor to direct the developmentof naive T-Helper cells toward the Th1 phenotype. Blood 90 (1997) 1920-1926
    • (1997) Blood , vol.90 , pp. 1920-1926
    • Hilkens, C.1    Kalinski, P.2    BoerF M.de3    Kapsenberg, M.4
  • 30
    • 33750286550 scopus 로고    scopus 로고
    • Cell-associated double-stranded RNA enhances antitumor activity through the production of type I IFN
    • McBride S., Hoebe K., Georgel P., and Janssen E. Cell-associated double-stranded RNA enhances antitumor activity through the production of type I IFN. J Immunol 177 9 (2006) 6122-6128
    • (2006) J Immunol , vol.177 , Issue.9 , pp. 6122-6128
    • McBride, S.1    Hoebe, K.2    Georgel, P.3    Janssen, E.4
  • 31
    • 0028145481 scopus 로고
    • In vivo antiviral effects of mismatched double-stranded RNA on Duck Hepatitis B Virus
    • Ijichi K., Mitamura K., Ida S., Machida H., and Shimada K. In vivo antiviral effects of mismatched double-stranded RNA on Duck Hepatitis B Virus. J Med Virol 43 (1994) 161-165
    • (1994) J Med Virol , vol.43 , pp. 161-165
    • Ijichi, K.1    Mitamura, K.2    Ida, S.3    Machida, H.4    Shimada, K.5
  • 32
    • 33846090134 scopus 로고    scopus 로고
    • Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists.
    • Welters M.J., Bijker M.S., van den Eeden S.J., Franken K.L., Melief C.J., Offringa R., et al. Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists. Vaccine 25 (2007) 1379-1389
    • (2007) Vaccine , vol.25 , pp. 1379-1389
    • Welters, M.J.1    Bijker, M.S.2    van den Eeden, S.J.3    Franken, K.L.4    Melief, C.J.5    Offringa, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.